These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6318931)

  • 1. [Affinity chromatography for the detection of human endogenous inhibitor of NA+, K+ -ATPase].
    Henning G; Cloix JF
    C R Seances Acad Sci III; 1983; 297(6):295-8. PubMed ID: 6318931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Affinity chromatographic study of the changes in the endogenous Na+-K+-ATPase inhibitor during sodium loading in man].
    Cloix JF; Henning G; Crabos M; Delva P; Meyer P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1251-5. PubMed ID: 6098236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity chromatography for human Na+, K+-ATPase inhibitors in plasma and urine.
    Henning G; Cloix JF; Wainer IW; Pernollet MG; Devynck MA; Meyer P
    Life Sci; 1985 May; 36(18):1787-98. PubMed ID: 2984510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
    Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation of the natriuretic hormone to essential hypertension.
    de Wardener HE; MacGregor GA
    Postgrad Med J; 1983; 59 Suppl 2():74-7. PubMed ID: 6310538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of endogenous Na+,K+-ATPase inhibitors in human plasma and urine using high-performance liquid chromatography.
    Crabos M; Wainer IW; Cloix JF
    FEBS Lett; 1984 Oct; 176(1):223-8. PubMed ID: 6208054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
    Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
    Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Na-K-ATPase inhibitor dissociated from hypertension-associated plasma protein.
    Weiler EW; Khalil-Manesh F; Gonick HC; Prins BA; Purdy RE; Sensharma DK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):364-73. PubMed ID: 10232496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of Na-K-ATPase inhibitors in plasma and urine of hypertensive patients: a preliminary report.
    Gonick HC; Weiler E; Khalil-Manesh F
    Klin Wochenschr; 1987; 65 Suppl 8():139-45. PubMed ID: 3599799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.
    Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the sodium to potassium ratio in daily urine of patients with arterial hypertension].
    Poseliugina OB
    Klin Med (Mosk); 2005; 83(8):57-9. PubMed ID: 16218366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for the sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme in degranulation of rat basophilic leukaemia cells.
    Gentile DA; Skoner DP
    Clin Exp Allergy; 1996 Dec; 26(12):1449-60. PubMed ID: 9027446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous sodium-potassium pump inhibitor in low renin hypertension.
    Haddy FJ; Pamnani MB
    Prog Clin Biol Res; 1985; 192():205-12. PubMed ID: 3001753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender difference in functional properties of Na,K-ATPase in the heart of spontaneously hypertensive rats.
    Vlkovicová J; Javorková V; Pechánová O; Vrbjar N
    Life Sci; 2005 Jan; 76(9):971-82. PubMed ID: 15607327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity.
    Bagrov AY; Dmitrieva RI; Fedorova OV; Kazakov GP; Roukoyatkina NI; Shpen VM
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):982-90. PubMed ID: 8896650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive assay and kinetic property of urinary inhibitor of Na+, K+-ATPase in sodium-loaded patients with essential hypertension.
    Masugi F; Ogihara T; Hasegawa T; Imai N; Nagano M; Tabuchi Y; Kumahara Y
    Jpn Circ J; 1985 Sep; 49(9):980-3. PubMed ID: 2999460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (Na+ + K+) ATPase inhibitors and intracellular electrolytes in essential hypertension.
    Iwaoka T; Nugent CA; Umeda T; Sato T
    Jpn Heart J; 1987 Sep; 28(5):695-705. PubMed ID: 2828706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct demonstration of an inhibitor of sodium, potassium dependent adenosine triphosphatase (Na+, K+-ATPase) in plasma from normotensive and hypertensive subjects.
    Roulston JE; Traill K; Wathen CG
    Clin Chim Acta; 1986 Sep; 159(2):163-71. PubMed ID: 3021362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte Na/K flux ratio in relation to sodium intake and a family history of essential hypertension in normotensive children.
    Uchiyama M; Satokata I
    J Hum Hypertens; 1993 Feb; 7(1):47-51. PubMed ID: 8383770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.